From: Prevalence and early outcome of bronchiectasis as an atypical presentation in COVID-19 patients
COVID-19 without bronchiectasis (n = 400) | COVID-19 with de novo bronchiectasis (n = 14) | P | |
---|---|---|---|
Leucocytes (103/μl) | 9.47 ± 4.01 | 11.12 ± 5.32 | 0.13 |
Lymphocytes (103/μl) | 1.18 ± 0.68 | 0.86 ± 0.47 | 0.09 |
CRP (mg/dl) | 51.64 ± 34.45 | 72.38 ± 52.69 | 0.21 |
D-dimer (ng) | 1.45 ± 1.22 | 1.93 ± 0.93 | 0.61 |
Serum ferritin | 489.74 ± 222.34 | 1392.97 ± 969.32 | < 0.001 |
SO2 at admission (%) | 84.38 ± 14.10 | 62.29 ± 15.67 | < 0.001 |
SO2 at discharge (%) | 88.78 ± 19.90 | 93.88 ± 1.47 | 0.53 |